IL162857A0 - Oral vaccination - Google Patents
Oral vaccinationInfo
- Publication number
- IL162857A0 IL162857A0 IL16285703A IL16285703A IL162857A0 IL 162857 A0 IL162857 A0 IL 162857A0 IL 16285703 A IL16285703 A IL 16285703A IL 16285703 A IL16285703 A IL 16285703A IL 162857 A0 IL162857 A0 IL 162857A0
- Authority
- IL
- Israel
- Prior art keywords
- vaccination
- oral vaccination
- oral
- drug
- simultaneous
- Prior art date
Links
- 238000002255 vaccination Methods 0.000 title abstract 3
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 239000003638 chemical reducing agent Substances 0.000 abstract 1
- 210000004211 gastric acid Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Materials For Photolithography (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02000901A EP1327450B1 (fr) | 2002-01-15 | 2002-01-15 | Vaccination orale par des mimotopes d'antigene tumoraux dénudés |
DE10259053A DE10259053A1 (de) | 2002-12-17 | 2002-12-17 | Antigen-Mimotope und Vakzine gegen Krebserkrankungen |
PCT/EP2003/000369 WO2003059380A2 (fr) | 2002-01-15 | 2003-01-15 | Vaccination orale |
Publications (1)
Publication Number | Publication Date |
---|---|
IL162857A0 true IL162857A0 (en) | 2005-11-20 |
Family
ID=26011230
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16285703A IL162857A0 (en) | 2002-01-15 | 2003-01-15 | Oral vaccination |
IL162857A IL162857A (en) | 2002-01-15 | 2004-07-05 | Use of an antigentically active substance and a gastric acid reducing substance for producing a vaccine for tumoral diseases |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL162857A IL162857A (en) | 2002-01-15 | 2004-07-05 | Use of an antigentically active substance and a gastric acid reducing substance for producing a vaccine for tumoral diseases |
Country Status (9)
Country | Link |
---|---|
US (2) | US20050226894A1 (fr) |
EP (1) | EP1465658B1 (fr) |
AT (1) | ATE361097T1 (fr) |
AU (1) | AU2003212215B9 (fr) |
CA (1) | CA2473416A1 (fr) |
DE (1) | DE50307169D1 (fr) |
ES (1) | ES2286409T3 (fr) |
IL (2) | IL162857A0 (fr) |
WO (1) | WO2003059380A2 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017135313A1 (fr) * | 2016-02-02 | 2017-08-10 | 日東電工株式会社 | Composition pour stimuler l'induction de l'immunité, et composition pharmaceutique vaccinale |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US471353A (en) * | 1892-03-22 | Can-testing machine | ||
NZ307017A (en) * | 1995-04-28 | 1999-07-29 | Oravax Inc | Vaccine containing multimeric complexes of helicobacter urease, composition of antigen (from gastroduodenal pathogen) and antibiotic, antisecretory agent, and/or bismuth salt |
US5840332A (en) * | 1996-01-18 | 1998-11-24 | Perio Products Ltd. | Gastrointestinal drug delivery system |
SE9600648D0 (sv) * | 1996-02-21 | 1996-02-21 | Bror Morein | Receptorbimdande enhet |
DE69718150T3 (de) * | 1996-03-01 | 2009-03-05 | Novartis Ag | Peptid-immunogene zur schutzimpfung gegen und behandlung von allergien |
US6403098B1 (en) * | 1996-09-26 | 2002-06-11 | Merck & Co., Inc. | Rotavirus vaccine formulations |
AU750792B2 (en) * | 1997-04-01 | 2002-07-25 | Human Genome Sciences, Inc. | 76 kDa, 32 kDa, and 50 kDa helicobacter polypeptides and corresponding polynucleotide molecules |
WO1999007869A1 (fr) * | 1997-08-05 | 1999-02-18 | University Of Florida | Vaccin vivant recombinant comprenant un virus ne se repliquant pas ou se repliquant sans efficacite |
GB0020089D0 (en) * | 2000-08-15 | 2000-10-04 | Smithkline Beecham Biolog | Vaccine Composition |
US6497859B1 (en) * | 2000-11-17 | 2002-12-24 | Noville Inc. | Cooling agents, pharmaceutical compositions having cooling agents and processes for making and using same |
CA2438921C (fr) * | 2001-02-21 | 2012-04-10 | Shire Biochem Inc. | Polypeptides de streptococcus pyogenes et fragments d'adn correspondants |
EP1327450B1 (fr) * | 2002-01-15 | 2007-08-15 | Bio Life Science Forschungs- und Entwicklungsges.m.b.H. | Vaccination orale par des mimotopes d'antigene tumoraux dénudés |
-
2003
- 2003-01-15 AU AU2003212215A patent/AU2003212215B9/en not_active Ceased
- 2003-01-15 CA CA002473416A patent/CA2473416A1/fr not_active Abandoned
- 2003-01-15 US US10/501,402 patent/US20050226894A1/en not_active Abandoned
- 2003-01-15 ES ES03708059T patent/ES2286409T3/es not_active Expired - Lifetime
- 2003-01-15 WO PCT/EP2003/000369 patent/WO2003059380A2/fr active IP Right Grant
- 2003-01-15 EP EP03708059A patent/EP1465658B1/fr not_active Expired - Lifetime
- 2003-01-15 IL IL16285703A patent/IL162857A0/xx active IP Right Grant
- 2003-01-15 DE DE50307169T patent/DE50307169D1/de not_active Expired - Lifetime
- 2003-01-15 AT AT03708059T patent/ATE361097T1/de active
-
2004
- 2004-07-05 IL IL162857A patent/IL162857A/en not_active IP Right Cessation
-
2010
- 2010-02-01 US US12/656,491 patent/US20100183684A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1465658A2 (fr) | 2004-10-13 |
US20100183684A1 (en) | 2010-07-22 |
DE50307169D1 (de) | 2007-06-14 |
WO2003059380A2 (fr) | 2003-07-24 |
IL162857A (en) | 2011-03-31 |
WO2003059380A3 (fr) | 2004-01-22 |
US20050226894A1 (en) | 2005-10-13 |
AU2003212215B9 (en) | 2008-02-21 |
AU2003212215A1 (en) | 2003-07-30 |
CA2473416A1 (fr) | 2003-07-24 |
EP1465658B1 (fr) | 2007-05-02 |
AU2003212215B2 (en) | 2007-10-11 |
ES2286409T3 (es) | 2007-12-01 |
ATE361097T1 (de) | 2007-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
MXPA03007712A (es) | Sales farmaceuticas. | |
TW200510375A (en) | New compounds | |
IL164798A0 (en) | Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them | |
HK1076605A1 (en) | Formulations | |
AP1787A (en) | Novel perindopril salt and pharmaceutical compositions containing same. | |
NO20062605L (no) | Farmasoytisk formulering inneholdende smakssubstanser med forbedrede farmasoytiske egenskaper | |
IL174655A0 (en) | Drug containing (2r)-2-propyloctanoic acid as the active ingredient | |
ATE260650T1 (de) | Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac | |
AU2003246567A1 (en) | Administration form for the oral administration of active substances, vitamins, and/or nutrients | |
WO2004091591A3 (fr) | Composition nutritionnelle ou therapeutique contenant le compose oleurofeine ou l'un de ses derives | |
GR1004358B (el) | Ανυδρη κρυσταλλικη μορφη της βαλακyκλοβιρης υδροχλωρικης | |
TW200509992A (en) | Dosage form containing pantoprazole as active ingredient | |
AU2003208673A1 (en) | Pacifier for administering flavour substances | |
TW200503785A (en) | Dosage form containing (S)-pantoprazole as active ingredient | |
AU2003246566A1 (en) | Administration form for the oral administration of active substances, vitamins, and/or nutrients | |
EP1273301A3 (fr) | Préparations pharmaceutiques comprenant des principes actifs susceptibles d'administration illicite | |
AP2001002369A0 (en) | Pharmaceutical complex. | |
IL162857A0 (en) | Oral vaccination | |
ZA200204905B (en) | Improved pharmaceutical dental formulations. | |
TNSN06299A1 (en) | Oral matrix formulations comprising licarbazepine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed |